| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ACLARIS THERAPEUTICS INC COM | 4,191,397 | 79,427,000 | 19.92% | ||
| 2 | SAGENT PHARMACEUTICALS INC | 6,499,737 | 79,102,000 | 19.84% | ||
| 3 | Biotie Therapies Corp. | 1,220,234 | 32,544,000 | 8.16% | ||
| 4 | Nabriva Therapeutics AG | 3,151,700 | 28,239,000 | 7.08% | ||
| 5 | EIGER BIOPHARMACEUTICALS INC | 1,599,592 | 26,825,000 | 6.73% | ||
| 6 | Ascendis Pharma | 1,419,332 | 26,329,000 | 6.60% | ||
| 7 | CODEXIS INC | 5,573,319 | 17,333,000 | 4.35% | ||
| 8 | ProNAi Therapeutics, Inc. | 2,438,270 | 16,434,000 | 4.12% | ||
| 9 | ADVANCED ACCELERATOR APPLIC | 455,798 | 15,962,000 | 4.00% | ||
| 10 | Agile Therapeutics, Inc. | 2,019,955 | 12,544,000 | 3.15% | ||
| 11 | REGENXBIO INC COM | 990,449 | 10,697,000 | 2.68% | ||
| 12 | TREVENA INC | 1,200,000 | 9,924,000 | 2.49% | ||
| 13 | Capnia, Inc. | 7,466,352 | 8,885,000 | 2.23% | ||
| 14 | KITE PHARMA INCORPORATED | 193,193 | 8,869,000 | 2.22% | ||
| 15 | AKARI THERAPEUTICS PLC | 527,842 | 7,390,000 | 1.85% | ||
| 16 | DYNAVAX TECHNOLOGIES CORP | 357,755 | 6,883,000 | 1.73% | ||
| 17 | MEI PHARMA INC | 2,767,718 | 3,487,000 | 0.87% | ||
| 18 | Carbylan Therapeutics Inc. | 4,204,562 | 2,691,000 | 0.67% | ||
| 19 | CHEMOCENTRYX INC | 887,906 | 2,211,000 | 0.55% | ||
| 20 | REVANCE THERAPEUTICS INC COM | 77,373 | 1,886,000 | 0.47% | ||
| 21 | OCERA THERAPEUTICS INC | 153,331 | 451,000 | 0.11% | ||
| 22 | Zosano Pharma Corp | 98,515 | 227,000 | 0.06% | ||
| 23 | Capnia, Inc. | 932,910 | 215,000 | 0.05% | ||
| 24 | PALATIN TECHNOLOGIES INC COM | 234,909 | 127,000 | 0.03% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001214659-16-011605, filed 2016.05.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
